Rafferty Asset Management, LLC Forma Therapeutics Holdings, Inc. Transaction History

Rafferty Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.1 - $10.0 $857,870 - $1.68 Million	-168,210 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.34 - $14.69 $428,325 - $754,449	51,358 Added 43.95%	168,210 $1.56 Million
Q4 2021 Feb 10, 2022	BUY	$13.6 - $24.89 $840,194 - $1.54 Million	61,779 Added 112.18%	116,852 $1.66 Million
Q3 2021 Nov 10, 2021	SELL	$21.22 - $25.7 $849,224 - $1.03 Million	-40,020 Reduced 42.09%	55,073 $1.28 Million
Q2 2021 Aug 10, 2021	BUY	$22.86 - $30.95 $4,686 - $6,344	205 Added 0.22%	95,093 $2.37 Million
Q1 2021 May 10, 2021	BUY	$24.58 - $42.82 $2.12 Million - $3.7 Million	86,425 Added 1021.21%	94,888 $2.66 Million
Q4 2020 Feb 10, 2021	BUY	$34.9 - $51.08 $295,358 - $432,290	8,463 New	8,463 $295,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.